Replies to post #4690 on Ayala Pharmaceuticals Inc (fka ADXS)

[jaxstraw]

PETX/Advaxis......

......conditional licensure in late-2016 or shortly thereafter.

Initiated AT-014 field study in dogs. During April 2016, Aratana initiated a field safety study for AT-014, an investigational canine osteosarcoma vaccine licensed from Advaxis, Inc. Aratana anticipates United States Department of Agriculture (USDA) conditional licensure in late-2016 or shortly thereafter.